Expression and regulation of drug transporters in vertebrate neutrophils
Abstract There remains a need to identify novel pro-resolution drugs for treatment of inflammatory disease. To date, there are no neutrophil-specific anti-inflammatory treatments in clinical use, perhaps due to our lack of understanding of how drugs access this complex cell type. Here we present the...
Main Authors: | Matthew J. Foulkes, Katherine M. Henry, Julien Rougeot, Edward Hooper-Greenhill, Catherine A. Loynes, Phil Jeffrey, Angeleen Fleming, Caroline O. Savage, Annemarie H. Meijer, Simon Jones, Stephen A. Renshaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-04785-4 |
Similar Items
-
Deletion of cftr Leads to an Excessive Neutrophilic Response and Defective Tissue Repair in a Zebrafish Model of Sterile Inflammation
by: Audrey Bernut, et al.
Published: (2020-07-01) -
Seeing is believing: methods to monitor vertebrate autophagy in vivo
by: Ana Lopez, et al.
Published: (2018-10-01) -
Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation
by: Atiqur Rahman, et al.
Published: (2019-10-01) -
Pioneer neutrophils release chromatin within in vivo swarms
by: Hannah M Isles, et al.
Published: (2021-07-01) -
Death receptor signalling and the regulation of neutrophil apoptosis
by: Renshaw, Stephen Andrew
Published: (2001)